Connection

Robert Gemmill to Quinazolines

Back to Details
This is a "connection" page, showing publications Robert Gemmill has written about Quinazolines.
Robert Gemmill
Connection Strength
0.614
Quinazolines
  1. MYC and EIF3H Coamplification significantly improve response and survival of non-small cell lung cancer patients (NSCLC) treated with gefitinib. J Thorac Oncol. 2009 Apr; 4(4):472-8.
    View in: PubMed
    Score: 0.303
  2. Synergistic growth inhibition by Iressa and Rapamycin is modulated by VHL mutations in renal cell carcinoma. Br J Cancer. 2005 Jun 20; 92(12):2266-77.
    View in: PubMed
    Score: 0.233
  3. Restoring E-cadherin expression increases sensitivity to epidermal growth factor receptor inhibitors in lung cancer cell lines. Cancer Res. 2006 Jan 15; 66(2):944-50.
    View in: PubMed
    Score: 0.061
  4. Upstream signaling inhibition enhances rapamycin effect on growth of kidney cancer cells. Urology. 2007 Mar; 69(3):596-602.
    View in: PubMed
    Score: 0.016
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.